Approved for use by diabetics to control blood sugar, liraglutide has also evidenced an ability to slow cognitive decline in a Phase 2b clinical trial, and reduce shrinkage of those areas of the brain ...
Positive results in a recent animal study strongly supports first-ever human investigation for DehydraTECH-liraglutide in an oral capsule format KELOWNA, BC / ACCESSWIRE / January 15, 2025 / Lexaria B ...
GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...
Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?
I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her ...
For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that from 2021 to 2023, those rates dropped from 41.9% to 40.3%.
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its ...
As Ozempic and other GLP-1 drugs explode in popularity ... with far less stringent oversight than their name brand inspiration. Meanwhile, as influencers on social media platforms like TikTok ...
Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...
With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.
The evolution of AI, more limited-time product offerings and GLP-1 use for weight loss are among the issues expected to play ...